Raporo Inyanja yasohoye raporo yubushakashatsi iheruka ku isoko rya Sodium Hyaluronate Amaso Y’ibitonyanga. Kugira ngo umuntu yumve neza isoko, hagomba gusuzumwa ibintu bitandukanye, birimo demografiya, uruzinduko rw’ubucuruzi, hamwe n’ibisabwa na mikoro y’ubukungu bifitanye isano neza n’isoko kuba yize.Ikindi kandi, ubushakashatsi bwisoko rya Sodium Hyaluronate Ijisho ryamasoko ryerekana isuzuma rirambuye ryimiterere yubucuruzi, ryerekana uburyo bushya ibigo bitera imbere, ibintu byimari nkigiciro cyumusaruro, uturere twingenzi, niterambere ryiterambere.
Amaso ya sodium hyaluronate yagabanije isoko ryinjije miliyoni USD muri 2016, yiyongera agera kuri miliyoni USD muri 2020, kandi azagera kuri miliyoni USD muri 2026, hamwe na CAGR ya% muri 2020-2026.
Ubukungu bwa digitale bugira ingaruka ku isi no ku mibereho myiza yabaturage basanzwe.Ikindi kandi, bigira ingaruka kuri byose kuva kugabana umutungo kugeza kugabana amafaranga no kuzamuka kwubukungu. Iyemezwa rya IoT ritera kuzamuka cyane kw isoko.Ikindi kandi, imbere Imyaka 5 kugeza 10, tekinoroji igezweho nka robotics, ubwenge bwubukorikori hamwe nukuri kwagutse irashobora kuba hafi 27% yikoreshwa rya ICT.Ikifuzo cyabakiriya igihe icyo aricyo cyose, aho ariho hose kugera kubicuruzwa nibicuruzwa bitera isoko rya ICT imbere. Inganda za ICT zinjiza amafaranga. kubatanga isoko kuko ifite abakoresha telefone zigera kuri miliyari 7 nabakoresha interineti miliyari 3.
Isi ya Sodium Hyaluronate Ijisho Ritakaza Ingamba zo Guteza Imbere Isoko Mbere na Nyuma ya COVID-19, ikubiyemo no gusesengura ubushobozi bw’inganda za Sodium Hyaluronate Eye Drops ku isi hifashishijwe isesengura ry’ingamba z’ubucuruzi, imiterere, ubwoko, ikoreshwa ndetse n’ibihugu 20 biyobora, bitanga amakuru ajyanye n’isoko Imibare ihamye, ibintu byiterambere, imbogamizi zingenzi, isesengura PEST hamwe nisesengura ryingamba zo kwinjiza isoko, amahirwe nibiteganijwe. Ikintu cyingenzi cyagaragaye muri raporo ni isesengura ry’ingamba z’ingaruka za COVID-19 ku masosiyete mu nganda. Hagati aho, iyi raporo isesengura isoko ry’isoko kuyobora ibihugu 20 kandi byerekana ubushobozi bwisoko ryibi bihugu.
Isi ya sodium hyaluronate igabanuka ku isoko ingano y’isoko yari ifite agaciro ka miliyoni USD mu 2021 bikaba biteganijwe ko izagera kuri miliyoni USD mu 2030 bitewe n’icyorezo cya COVID-19, ikura kuri CAGR ikomeye mu gihe cyateganijwe. Igice cy’ibitaro ku isi ni birashoboka gukura kuri CAGR yubahwa mugihe cyateganijwe.
Raporo y'ubushakashatsi ikubiyemo amakuru n'ubugenzuzi byaturutse mu bihugu bikomeye nk'Ubushinwa, Kanada, Mexico, Ubuhinde, Ubudage, Ubufaransa, Amerika, Uburusiya, Ubutaliyani, Ubuyapani, Koreya y'Epfo, Aziya y'Amajyepfo y'Uburasirazuba, Ositaraliya, Burezili, Ubwongereza, na Arabiya Sawudite. Arabiya.Iterambere ku masoko y'ingenzi yo mu karere naryo rirasuzumwa, harimo Amerika y'Amajyaruguru, Uburayi, Aziya ya pasifika, Amerika y'Epfo n'Uburasirazuba bwo hagati, na Afurika.
Abakinnyi bakomeye mumasoko ya sodium hyaluronate yamaso ni: Santen Pharmaceutical Co., Ltd. Scope Ophthalmics Ltd Medicom Healthcare Bausch & Lomb TRB Chemedica International SA Altacor Limited Thea Pharmaceuticals Limited Mid-Optic Ltd Alcon Abbott Medical Optics Inc.
Raporo irasuzuma kandi ingano y’isoko n’amateka ya none.Mu gihe cyateganijwe, raporo isesengura umuvuduko w’ubwiyongere, ingano y’isoko ndetse n’agaciro k’isoko. Raporo yerekana imigendekere y’inganda muri iki gihe ndetse n’ubushobozi buzaza muri Amerika y'Amajyaruguru, Aziya ya pasifika, Uburayi , Amerika y'Epfo, n'Uburasirazuba bwo hagati & Afurika. Raporo itanga ishusho yuzuye ku isoko hashingiwe ku turere, imiterere y'isoko, n'imikorere y'amafaranga y'abakinnyi bakomeye.
Igihe cyo kohereza: Jun-21-2022